169
Views
0
CrossRef citations to date
0
Altmetric
Letters

Refractory systemic lupus erythematosus with neuropsychiatric manifestations successfully treated with anifrolumab

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 226-228 | Received 01 Nov 2023, Accepted 12 Jan 2024, Published online: 26 Jan 2024
 

Disclosure statement

SH has received speaking fees from AstraZeneca. The other authors declare no conflicts of interest associated with this manuscript.

Patient consent

Written, informed consent was obtained from the four patients by the corresponding author. The signed consent forms are retained by the corresponding author. Patient details were anonymized as much as possible.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 171.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.